Abeona Therapeutics (ABEO)
NASDAQ:ABEO

Abeona Therapeutics (ABEO) Stock Price & Analysis

1,195 Followers

ABEO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.19 - $5.40
Previous Close$4.34
Volume67.52K
Average Volume (3M)129.83K
Market Cap
$107.44M
Enterprise Value$76.64M
Total Cash (Recent Filing)$36.77M
Total Debt (Recent Filing)$5.97M
Price to Earnings (P/E)-1.4
Beta1.39
Nov 13, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.00
Shares Outstanding24,755,873
10 Day Avg. Volume112,141
30 Day Avg. Volume129,833
Standard Deviation0.25
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)11.29
Price to Sales (P/S)30.70
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue21.48
Enterprise Value/Gross Profit49.29
Enterprise Value/Ebitda-6.47
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ABEO FAQ

What was Abeona Therapeutics’s price range in the past 12 months?
Abeona Therapeutics lowest stock price was $2.19 and its highest was $5.40 in the past 12 months.
    What is Abeona Therapeutics’s market cap?
    Currently, no data Available
    When is Abeona Therapeutics’s upcoming earnings report date?
    Abeona Therapeutics’s upcoming earnings report date is Nov 13, 2023 which is in 25 days.
      How were Abeona Therapeutics’s earnings last quarter?
      Abeona Therapeutics released its earnings results on Aug 08, 2023. The company reported -$0.92 earnings per share for the quarter, missing the consensus estimate of -$0.673 by -$0.247.
        Is Abeona Therapeutics overvalued?
        According to Wall Street analysts Abeona Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Abeona Therapeutics pay dividends?
          Abeona Therapeutics does not currently pay dividends.
          What is Abeona Therapeutics’s EPS estimate?
          Abeona Therapeutics’s EPS estimate is -$0.53.
            How many shares outstanding does Abeona Therapeutics have?
            Abeona Therapeutics has 24,755,873 shares outstanding.
              What happened to Abeona Therapeutics’s price movement after its last earnings report?
              Abeona Therapeutics reported an EPS of -$0.92 in its last earnings report, missing expectations of -$0.673. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Abeona Therapeutics?
                Among the largest hedge funds holding Abeona Therapeutics’s share is Deerfield Management Company, LP. It holds Abeona Therapeutics’s shares valued at 4M.

                  ---

                  Abeona Therapeutics Stock Smart Score

                  The Abeona Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Abeona Therapeutics

                  Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

                  ---

                  Top 5 ETFs holding ABEO

                  Name
                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  $1.92M
                  8
                  iShares Core S&P Total U.S. Stock Market ETF
                  $4.73K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold ABEO. The ETFs are listed according to market value of ABEO within the ETF

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  BioCryst
                  Corbus Pharmaceuticals
                  Voyager Therapeutics
                  SAGE Therapeutics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis